Ovid Therapeutics Inc. (1OT)
XDUS
2.10
+0.02 (+0.96%)
Real-time Data
06:00 AM
Day's Range
2.082.10
52 wk Range
0.98002.48
Financial Statements - 1OT - Ovid Therapeutics Inc.
Revenue
7.25M▲ 1181.3%
Net Income
-17.41M▲ 34.1%Net Margin -240.1%
EBITDA
-42.16M▲ 34.7%
Free Cash Flow
-38.33M▲ 31.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 7.25M | 566K | 391.69K | 1.50M | 208.38M | 12.61M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -42.43M | -61.88M | -59.28M | -55.54M | 124.21M | -81.43M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 25.02M | 31.50M | 2M | 1.37M | -45.69K | 395.40K |
| Pre Tax Income | -17.41M | -26.43M | -52.33M | -54.16M | 124.16M | -81.03M |
| Income Tax | 0 | 0 | 0 | 0 | 1.32M | 0 |
| Net Income | -17.41M | -26.43M | -52.33M | -54.16M | 122.83M | -81.03M |
| EPS Basic | -0.23 | -0.37 | -0.74 | -0.77 | 1.78 | -1.39 |
| EPS Diluted | -0.23 | -0.37 | -0.74 | -0.77 | 1.76 | -1.39 |
| Basic Shares Outstanding | 73.73M | 70.90M | 76.43M | 73.63M | 70.55M | 61.11M |
| Diluted Shares Outstanding | 73.73M | 70.90M | 76.43M | 73.63M | 70.55M | 61.11M |
| Ebit | -42.43M | -61.88M | -59.28M | -55.54M | 124.21M | -81.43M |
| Ebitda | -42.16M | -64.57M | -59.68M | -54.16M | 124.44M | -81.12M |
| Net Income Continuous Operations | -17.41M | -26.43M | -52.33M | -54.16M | 122.83M | -81.03M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | 0 | 0 | 2.99M | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
